[tdb_mobile_menu menu_id="81451" el_class="plato-left-menu" icon_size="eyJhbGwiOjUwLCJwaG9uZSI6IjMwIn0=" icon_padding="eyJhbGwiOjAuNSwicGhvbmUiOiIxLjUifQ==" tdc_css="eyJhbGwiOnsibWFyZ2luLXRvcCI6IjEwIiwibWFyZ2luLWJvdHRvbSI6IjAiLCJtYXJnaW4tbGVmdCI6IjE1IiwiZGlzcGxheSI6IiJ9LCJwaG9uZSI6eyJtYXJnaW4tdG9wIjoiMCIsIm1hcmdpbi1sZWZ0IjoiMCIsImRpc3BsYXkiOiIifSwicGhvbmVfbWF4X3dpZHRoIjo3Njd9" align_horiz="content-horiz-center" inline="yes" icon_color="#ffffff" icon_color_h="#ffffff"][tdb_header_logo align_vert="content-vert-center" url="https://zephyrnet.com" inline="yes" text="Zephyrnet" image_width="eyJwaG9uZSI6IjM1In0=" img_txt_space="eyJwaG9uZSI6IjEwIn0=" f_text_font_size="eyJwaG9uZSI6IjE4In0=" f_text_font_line_height="eyJwaG9uZSI6IjEuNSJ9" f_text_font_weight="eyJwaG9uZSI6IjcwMCJ9" f_text_font_transform="eyJwaG9uZSI6ImNhcGl0YWxpemUifQ==" f_text_font_family="eyJwaG9uZSI6ImZzXzIifQ==" text_color="#ffffff" text_color_h="var(--accent-color)"]

[tdb_mobile_horiz_menu menu_id="1658" single_line="yes" f_elem_font_family="eyJwaG9uZSI6ImZzXzIifQ==" f_elem_font_weight="eyJwaG9uZSI6IjcwMCJ9" text_color="var(--news-hub-white)" text_color_h="var(--news-hub-accent-hover)" f_elem_font_size="eyJwaG9uZSI6IjE0In0=" f_elem_font_line_height="eyJwaG9uZSI6IjQ4cHgifQ==" elem_padd="eyJwaG9uZSI6IjAgMTVweCJ9" tdc_css="eyJwaG9uZSI6eyJwYWRkaW5nLXJpZ2h0IjoiNSIsInBhZGRpbmctbGVmdCI6IjUiLCJkaXNwbGF5Ijoibm9uZSJ9LCJwaG9uZV9tYXhfd2lkdGgiOjc2N30="]

[tdb_mobile_menu inline="yes" menu_id="81451" el_class="plato-left-menu" icon_size="50" icon_padding="0.5" tdc_css="eyJhbGwiOnsibWFyZ2luLXRvcCI6IjEwIiwibWFyZ2luLWJvdHRvbSI6IjAiLCJtYXJnaW4tbGVmdCI6IjE1IiwiZGlzcGxheSI6IiJ9fQ==" icon_color="#ffffff" icon_color_h="#ffffff"]

Generative Data Intelligence

[tdb_header_menu main_sub_tdicon="td-icon-down" sub_tdicon="td-icon-right-arrow" mm_align_horiz="content-horiz-center" modules_on_row_regular="20%" modules_on_row_cats="20%" image_size="td_300x0" modules_category="image" show_excerpt="none" show_com="none" show_date="" show_author="none" mm_sub_align_horiz="content-horiz-right" mm_elem_align_horiz="content-horiz-center" menu_id="81450" show_mega_cats="yes" align_horiz="content-horiz-center" elem_padd="0 30px" main_sub_icon_space="12" mm_width="1192" mm_padd="30px 25px" mm_align_screen="yes" mm_sub_padd="20px 25px 0" mm_sub_border="1px 0 0" mm_elem_space="25" mm_elem_padd="0" mm_elem_border="0" mm_elem_border_a="0" mm_elem_border_rad="0" mc1_title_tag="h2" modules_gap="25" excl_txt="Premium" excl_margin="0 6px 0 0" excl_padd="2px 5px 2px 4px" excl_bg="var(--news-hub-accent)" f_excl_font_size="12" f_excl_font_weight="700" f_excl_font_transform="uppercase" meta_padding="20px 0 0" art_title="0 0 10px" show_cat="none" show_pagination="disabled" text_color="var(--news-hub-white)" tds_menu_active1-line_color="var(--news-hub-accent)" f_elem_font_size="18" f_elem_font_line_height="64px" f_elem_font_weight="400" f_elem_font_transform="none" mm_bg="var(--news-hub-dark-grey)" mm_border_color="var(--news-hub-accent)" mm_subcats_border_color="#444444" mm_elem_color="var(--news-hub-white)" mm_elem_color_a="var(--news-hub-accent-hover)" f_mm_sub_font_size="14" title_txt="var(--news-hub-white)" title_txt_hover="var(--news-hub-accent-hover)" date_txt="var(--news-hub-light-grey)" f_title_font_line_height="1.25" f_title_font_weight="700" f_meta_font_line_height="1.3" f_meta_font_family="fs_2" tdc_css="eyJhbGwiOnsiYm9yZGVyLXRvcC13aWR0aCI6IjEiLCJib3JkZXItcmlnaHQtd2lkdGgiOiIxIiwiYm9yZGVyLWJvdHRvbS13aWR0aCI6IjEiLCJib3JkZXItbGVmdC13aWR0aCI6IjEiLCJib3JkZXItY29sb3IiOiJ2YXIoLS1uZXdzLWh1Yi1kYXJrLWdyZXkpIiwiZGlzcGxheSI6IiJ9fQ==" mm_border_size="4px 0 0" f_elem_font_family="fs_2" mm_subcats_bg="var(--news-hub-dark-grey)" mm_elem_bg="rgba(0,0,0,0)" mm_elem_bg_a="rgba(0,0,0,0)" f_mm_sub_font_family="fs_2" mm_child_cats="10" mm_sub_inline="yes" mm_subcats_posts_limit="5"]

Home Crowdfunding [Alpha Tau in PR Newswire] Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment of Solid Tumors Through the Precision Delivery of Alpha Radiation

Crowdfunding

[Alpha Tau in PR Newswire] Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment of Solid Tumors Through the Precision Delivery of Alpha Radiation

Republished By Plato

-

July 8, 2021

– Alpha Tau’s proprietary Alpha DaRT™ is designed to deliver uniquely potent alpha radiation to destroy solid tumors with localized precision, sparing surrounding healthy tissue, thereby maintaining cancer patients’ quality of life. Alpha DaRT™ has recently received FDA’s Breakthrough Device Designation for the indication of Squamous Cell Carcinoma of the skin and oral cavity without curative standard of care, and preclinical studies support evaluation across various cancer indications (skin, pancreas, breast and GBM, among others).

Read more here.

PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.

Source: https://blog.ourcrowd.com/alpha-tau-and-healthcare-capital-corp-to-combine-and-create-a-publicly-traded-company-focused-on-transforming-the-treatment-of-solid-tumors-through-the-precision-delivery-of-alpha-radiation/